Bayer initiates public dialogue on tackling vector borne diseases in India
National dialogue on 'Protecting Communities: Vector Control in Action' sees support and participation from key public and private…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
FOPE, HDMA members meet DGCI, state regulators
The September 21st meet saw productive discussions on the many recent regulatory changes
TAKE Solutions to receive Golden Peacock Award for excellence in corporate governance
The World Council for Corporate Governance, UK, confers the award annually, to companies that have demonstrated benchmark…
GSK candidate vaccine helps prevent active pulmonary tuberculosis in HIV negative adults
Publication of primary results in the New England Journal of Medicine shows positive impact of innovative vaccine technology in…
AstraZeneca announces positive results from Phase III DECLARE-TIMI 58
Forxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000…
Dr Manoj Nerurkar, COO steps down from role at Syngene
The announcement of the appointment of his successor will be made shortly
Netmeds strengthens its healthcare expertise with acquisition of JustDoc.com
With this acquisition, Netmeds marks its entry into the diagnostics, offering end-to-end consultancy in the healthcare, lifestyle…
Novartis to cut 2,200 jobs in Switzerland to boost profitability
About 1,500 positions will be cut from Novartis's production sites in Basel, Stein, Locarno and Schweizerhalle
EU approves AstraZeneca immunotherapy drug for lung cancer
The green light from the EU had been expected following a positive recommendation from experts at the European Medicines Agency
USFDA completes inspection of Biocon’s drug substance unit at Bengaluru
The week-long audit concluded without any observations and no Form 483 was issued